跳至主要内容
临床试验/NCT02957851
NCT02957851已完成2 期

Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) for the Treatment of Peripheral Neuropathic Pain: A Randomises, International, Multicentre, Placebo-Controlled, Phenotype-stratified Phase IIa Study

Air Liquide Santé International22 个研究点 分布在 2 个国家目标入组 287 人开始时间: 2016年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
287
试验地点
22
主要终点
Pain intensity

研究概览

简要总结

To assess the effect of 3 consecutive days of one-hour administration of Nitrous Oxide/Oxygen 50%/50% (EMONO) versus placebo as Oxygen/Nitrogen 22%/78% (synthetic medical air), in add-on therapy to chronic analgesic treatments, on average pain intensity in patients with chronic peripheral neuropathic pain. A total of 250 randomised patients to be included in all the participating centres, i.e., 125 randomised patients in each of the 2 study groups treatments

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with a mean pain intensity from 4 to 9 as assessed daily with a Numerating Rating Scale during the 7 day period preceding inclusion in spite of administration of usual pain treatments.
  • Neuropathic pain lasting for more than 3 months but less than 10 years
  • Definite or probable peripheral neuropathy

排除标准

  • legal incapacity
  • patient with another concomitant chronic pain
  • ongoing major depression
  • Chemotherapy-induced peripheral neuropathic pain

研究组 & 干预措施

Oxygen/Nitrogen (22%/78%)

Placebo Comparator

Medical Air

干预措施: Medical Air (Drug)

Nitrous Oxide/Oxygen (50%/50%)

Active Comparator

EMONO

干预措施: EMONO (Drug)

结局指标

主要结局

Pain intensity

时间窗: 7 days after the last administration of treatment

Numeric Rating Scale (NRS)

次要结局

  • Pain intensity(28 days after the last administration of treatment)
  • Pain characteristic(28 days after the last administration of treatment)
  • Quality of life questionnaire(28 days after the last administration of treatment)
  • Number of patients with adverse events(through study duration, up to 31 days)

研究者

发起方
Air Liquide Santé International
申办方类型
Industry
责任方
Sponsor

研究点 (22)

Loading locations...

相似试验